Invacare Corporation (IVC): Price and Financial Metrics


Invacare Corporation (IVC)

Today's Latest Price: $6.34 USD

0.08 (-1.25%)

Updated Jul 7 4:10pm

Add IVC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

IVC Stock Summary

  • Invacare Corp's stock had its IPO on March 26, 1990, making it an older stock than 84.15% of US equities in our set.
  • IVC's price/sales ratio is 0.24; that's higher than the P/S ratio of merely 10.58% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Invacare Corp is reporting a growth rate of -97.06%; that's higher than only 17.09% of US stocks.
  • Stocks that are quantitatively similar to IVC, based on their financial statements, market capitalization, and price volatility, are MTW, FLOW, CMT, NP, and ORN.
  • Visit IVC's SEC page to see the company's official filings. To visit the company's web site, go to www.invacare.com.
IVC Daily Price Range
IVC 52-Week Price Range

IVC Stock Price Chart Technical Analysis Charts


IVC Price/Volume Stats

Current price $6.34 52-week high $11.63
Prev. close $6.42 52-week low $3.90
Day low $6.25 Volume 336,173
Day high $6.59 Avg. volume 447,563
50-day MA $6.69 Dividend yield 0.78%
200-day MA $7.59 Market Cap 218.25M

Invacare Corporation (IVC) Company Bio


Invacare Corporation designs, manufactures, and distributes medical equipment and supplies used in the home and long-term care settings. It operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. The company was founded in 1885 and is based in Elyria, Ohio.

IVC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$6.34$0.61-91%

Below please find a table outlining a discounted cash flow forecast for IVC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Invacare Corp ranked in the 11th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Invacare Corp, consider:

  • As a business, IVC is generating more cash flow than merely 11.18% of positive cash flow stocks in the Healthcare.
  • 43% of the company's capital comes from equity, which is greater than merely 24.07% of stocks in our cash flow based forecasting set.
  • Invacare Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.01. This coverage rate is greater than that of only 23.41% of stocks we're observing for the purpose of forecasting via discounted cash flows.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-91%
1%-91%
2%-91%
3%-90%
4%-90%
5%-90%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as IVC, try DYNT, IDXX, LCTC, RGEN, and CRY.


IVC Latest News Stream


Event/TimeNews Detail
Loading, please wait...

IVC Latest Social Stream


Loading social stream, please wait...

View Full IVC Social Stream

Latest IVC News From Around the Web

Below are the latest news stories about Invacare Corp that investors may wish to consider to help them evaluate IVC as an investment opportunity.

Invacare Corporation to Present at the 20th Annual CJS Securities New Ideas Summer Conference

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC)(the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matthew E. Monaghan, chairman, president and chief executive officer will present at the 20th Annual New Ideas Summer Conference on Tuesday, July 14, 2020. In addition, the Company will be available to host 1x1 investor meetings. A copy of the updated IR presentation will be posted on the Company’s websit

Business Wire | July 1, 2020

Invacare Corporation (IVC): Hedge Funds Are Getting Interested

In this article you are going to find out whether hedge funds think Invacare Corporation (NYSE:IVC) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]

Yahoo | June 23, 2020

Invacare Corporation Completes Private Exchange to Retire Approximately $35 Million Principal Amount of Its 5.0% Convertible Senior Notes Due 2021 and Approximately $39 Million Principal Amount of Its 4.5% Convertible Senior Notes Due 2022

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (the “Company”) announced the completion today of its previously announced separate private exchange transactions in which certain holders of its 5.0% Convertible Senior Notes due 2021 (the “2021 Notes”) and certain holders of its 4.5% Convertible Senior Notes due 2022 (the “2022 Notes”) exchanged approximately $35.4 million in aggregate principal amount of 2021 Notes and $38.5 million in aggregate principal amount of 2022 Notes, f

Business Wire | June 4, 2020

Invacare launches debt exchange offer

Invacare (IVC) has entered into separate, privately negotiated agreements with certain holders of its 5.0% Convertible Senior Notes due 2021 and 4.5% Convertible Senior Notes due 2022 to exchange ~$32.9M of 2021 Notes and $38.5M of 2022 Notes, for aggregate consideration of ~$71.4M in aggregate principal amount of new 5.0%...

Seeking Alpha | June 1, 2020

Invacare Corporation Announces Private Exchange to Retire Approximately $33 Million Principal Amount of Its 5.0% Convertible Senior Notes Due 2021 and Approximately $39 Million Principal Amount of Its 4.5% Convertible Senior Notes Due 2022

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (the “Company”) entered into separate, privately negotiated agreements with certain holders of its 5.0% Convertible Senior Notes due 2021 (the “2021 Notes”) and certain holders of its 4.5% Convertible Senior Notes due 2022 (the “2022 Notes”) to exchange approximately $32.9 million in aggregate principal amount of 2021 Notes and $38.5 million in aggregate principal amount of 2022 Notes, for aggregate consideration of approximately $

Business Wire | June 1, 2020

Read More 'IVC' Stories Here

IVC Price Returns

1-mo -19.34%
3-mo 9.31%
6-mo -28.14%
1-year 24.98%
3-year -50.79%
5-year -68.10%
YTD -29.47%
2019 111.71%
2018 -74.40%
2017 29.50%
2016 -24.65%
2015 4.05%

IVC Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full IVC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0078 seconds.